Eric L. Simpson
Impact in
- Dermatology top 0.01%
- Dermatology and Skin Diseases
- Contact Dermatitis and Allergies
- Immunology and Allergy top 0.02%
- Allergic Rhinitis and Sensitization
- Food Allergy and Anaphylaxis Research
Papers in
- Dermatology 318
- Dermatology and Skin Diseases 306
- Contact Dermatitis and Allergies 19
-
- Allergic Rhinitis and Sensitization 80
- Food Allergy and Anaphylaxis Research 58
- Co-authors
- Jonathan I. Silverberg (99 shared papers)Caroline Koudelka (2 shared papers)Amy S. Paller (50 shared papers)Lawrence F. Eichenfield (56 shared papers)Andrew Blauvelt (49 shared papers)Emma Guttman‐Yassky (45 shared papers)Tatyana Shaw (1 shared paper)Jon M. Hanifin (13 shared papers)
- Journals
- Journal of the American Academy of Dermatology (56 papers)British Journal of Dermatology (29 papers)Dermatology and Therapy (26 papers)Journal of Investigative Dermatology (19 papers)American Journal of Clinical Dermatology (17 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Eric L. Simpson
318 papers receiving 11.3k citations
Eric L. Simpson's Hit Papers
Peers
Comparison fields: 5 of 130
- Dermatology 9.4k
- Immunology and Allergy 4.6k
- Rheumatology 1.5k
- Physiology 1.9k
- Immunology 901
Countries citing papers authored by Eric L. Simpson
This map shows the geographic impact of Eric L. Simpson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric L. Simpson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric L. Simpson more than expected).
Fields of papers citing papers by Eric L. Simpson
This network shows the impact of papers produced by Eric L. Simpson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric L. Simpson. The network helps show where Eric L. Simpson may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric L. Simpson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 345 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Eczema Prevalence in the United States: Data from the 2003 National Survey of Children's Health Hit paper breakdown → | 2010 | 588 |
| 2 | Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention Hit paper breakdown → | 2014 | 497 |
| 3 | Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults Hit paper breakdown → | 2016 | 437 |
| 4 | Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials Hit paper breakdown → | 2021 | 372 |
| 5 | Mental health comorbidity in patients with atopic dermatitis Hit paper breakdown → | 2012 | 357 |
| 6 | Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial Hit paper breakdown → | 2020 | 336 |
| 7 | Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis Hit paper breakdown → | 2021 | 326 |
| 8 | Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis Hit paper breakdown → | 2021 | 310 |
| 9 | Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis Hit paper breakdown → | 2020 | 307 |
| 10 | Atopic dermatitis in the pediatric population Hit paper breakdown → | 2021 | 272 |
| 11 | Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE) Hit paper breakdown → | 2018 | 256 |
| 12 | Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis Hit paper breakdown → | 2020 | 255 |
| 13 | Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study Hit paper breakdown → | 2018 | 254 |
| 14 | Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults Hit paper breakdown → | 2016 | 238 |
| 15 | Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies Hit paper breakdown → | 2021 | 225 |
| 16 | Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis Hit paper breakdown → | 2020 | 204 |
| 17 | 2016 | 192 | |
| 18 | Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis Hit paper breakdown → | 2023 | 182 |
| 19 | 2015 | 169 | |
| 20 | 2018 | 145 |
About Eric L. Simpson
Eric L. Simpson is a scholar working on Dermatology, Immunology and Allergy, Physiology, Rheumatology and Immunology, having authored 345 papers that have together received 11.7k indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (306 papers), Allergic Rhinitis and Sensitization (80 papers), Asthma and respiratory diseases (60 papers), Food Allergy and Anaphylaxis Research (58 papers), Urticaria and Related Conditions (49 papers), Contact Dermatitis and Allergies (19 papers), Transgenic Plants and Applications (15 papers) and IL-33, ST2, and ILC Pathways (14 papers). The work is most often cited by research in Dermatology (9.4k citations), Immunology and Allergy (4.6k citations), Rheumatology (1.5k citations), Physiology (1.9k citations) and Immunology (901 citations). Eric L. Simpson has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Jonathan I. Silverberg, Caroline Koudelka, Amy S. Paller, Lawrence F. Eichenfield, Andrew Blauvelt, Emma Guttman‐Yassky, Tatyana Shaw, Jon M. Hanifin, Thomas Bieber and Jacob P. Thyssen. Their work appears in journals such as Journal of the American Academy of Dermatology, British Journal of Dermatology, Dermatology and Therapy, Journal of Investigative Dermatology and American Journal of Clinical Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.